| Business Summary | | Dianon
Systems,
Inc.
provides
a
full
line
of
anatomic
pathology
testing
services
and
a
number
of
genetic
and
clinical
chemistry
testing
services
to
patients,
physicians
and
managed-care
organizations
throughout
the
United
States.
The
Company's
principal
physician
audience
for
these
services
includes
approximately
50,000
clinicians
engaged
in
the
fields
of
medical
oncology,
urology,
dermatology,
gynecology
and
gastroenterology.
Dianon
performs
all
testing
at
either
its
main
facility
in
Stratford,
Connecticut,
or
at
its
other
facilities
located
in
Tampa,
Florida;
New
City,
New
York;
Woodbury,
New
York,
or
Englewood,
Colorado
(acquired
in
October
2000).
The
Company
provides
most
test
results
to
physicians
within
48
hours. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Dianon
Systems,
Inc.
provides
a
full
line
of
anatomic
pathology
testing
services
and
a
number
of
genetic
and
clinical
chemistry
testing
services.
For
the
six
months
ended
6/30/01,
net
revenues
increased
19%
to
$55.6
million.
Net
income
rose
56%
to
$4.4
million.
Revenues
reflect
strong
volume
gains
in
pathology
and
genetics
and
a
favorable
reimbursement
climate.
Earnings
also
benefited
from
higher
margins
due
to
increased
revenues
and
efficiencies. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| John Davis, 59 Non
- Exec. Chairman | -- | -- | Kevin Johnson, 46 Pres,
CEO, Director | $410K | $507K | David Schreiber, 41 CFO,
Sr. VP-Fin., Sec., Director | 269K | 972K | Martin Stefanellli, 39 Sr.
VP of Sales, Marketing and Bus. Devel. | 248K | 421K | Jack Snyder, 49 Sr.
VP, CMO | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|